Cargando…

Novel KCNJ16 variants identified in a Chinese patient with hypokalemic metabolic acidosis

BACKGROUND: Biallelic pathogenic variants in the KCNJ16 gene result in hypokalemic tubulopathy and deafness (HKTD) (MIM #619406), which is a rare autosomal recessive disease characterized by hypokalemic tubulopathy with renal salt wasting, disturbed acid–base homeostasis, and sensorineural deafness....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jianxiong, Fu, Youqing, Sun, Yan, Zhou, Xinlong, Wang, Qingming, Li, Cong, Yuan, Haiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655507/
https://www.ncbi.nlm.nih.gov/pubmed/37466410
http://dx.doi.org/10.1002/mgg3.2238
_version_ 1785136840223752192
author Chen, Jianxiong
Fu, Youqing
Sun, Yan
Zhou, Xinlong
Wang, Qingming
Li, Cong
Yuan, Haiming
author_facet Chen, Jianxiong
Fu, Youqing
Sun, Yan
Zhou, Xinlong
Wang, Qingming
Li, Cong
Yuan, Haiming
author_sort Chen, Jianxiong
collection PubMed
description BACKGROUND: Biallelic pathogenic variants in the KCNJ16 gene result in hypokalemic tubulopathy and deafness (HKTD) (MIM #619406), which is a rare autosomal recessive disease characterized by hypokalemic tubulopathy with renal salt wasting, disturbed acid–base homeostasis, and sensorineural deafness. Currently, nine individuals with HKTD have been reported, and seven pathogenic variants in KCNJ16 have been revealed. METHODS: A 5‐year‐6‐month‐old Chinese female patient displayed hypokalemic metabolic acidosis, salt wasting, renin‐angiotensin‐aldosterone system (RAAS) activation, arrhythmia, myocardial damage, cardiogenic shock and secondary diffuse brain oedema. Trio‐based whole‐exome sequencing (WES) was applied to detect the genetic cause. RESULTS: Novel compound heterozygous variants, c.190A>C (p.Thr64Pro) and c.628C>G (p.His210Asp), in KCNJ16 were detected in the patient, and these variants were inherited from the patient's mother and father, respectively. Then, we systematically reviewed the available clinical manifestations of individuals with HKTD. We found that HKTD patients are at risk of cardiogenic shock and secondary diffuse brain oedema, which urges clinicians to make early diagnoses with prompt treatments. CONCLUSION: These findings expand the variant spectrum of KCNJ16, enrich the clinical characteristics of HKTD, and provide a solid base for the genetic counseling, diagnosis and treatment of this condition.
format Online
Article
Text
id pubmed-10655507
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106555072023-07-19 Novel KCNJ16 variants identified in a Chinese patient with hypokalemic metabolic acidosis Chen, Jianxiong Fu, Youqing Sun, Yan Zhou, Xinlong Wang, Qingming Li, Cong Yuan, Haiming Mol Genet Genomic Med Original Articles BACKGROUND: Biallelic pathogenic variants in the KCNJ16 gene result in hypokalemic tubulopathy and deafness (HKTD) (MIM #619406), which is a rare autosomal recessive disease characterized by hypokalemic tubulopathy with renal salt wasting, disturbed acid–base homeostasis, and sensorineural deafness. Currently, nine individuals with HKTD have been reported, and seven pathogenic variants in KCNJ16 have been revealed. METHODS: A 5‐year‐6‐month‐old Chinese female patient displayed hypokalemic metabolic acidosis, salt wasting, renin‐angiotensin‐aldosterone system (RAAS) activation, arrhythmia, myocardial damage, cardiogenic shock and secondary diffuse brain oedema. Trio‐based whole‐exome sequencing (WES) was applied to detect the genetic cause. RESULTS: Novel compound heterozygous variants, c.190A>C (p.Thr64Pro) and c.628C>G (p.His210Asp), in KCNJ16 were detected in the patient, and these variants were inherited from the patient's mother and father, respectively. Then, we systematically reviewed the available clinical manifestations of individuals with HKTD. We found that HKTD patients are at risk of cardiogenic shock and secondary diffuse brain oedema, which urges clinicians to make early diagnoses with prompt treatments. CONCLUSION: These findings expand the variant spectrum of KCNJ16, enrich the clinical characteristics of HKTD, and provide a solid base for the genetic counseling, diagnosis and treatment of this condition. John Wiley and Sons Inc. 2023-07-19 /pmc/articles/PMC10655507/ /pubmed/37466410 http://dx.doi.org/10.1002/mgg3.2238 Text en © 2023 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Chen, Jianxiong
Fu, Youqing
Sun, Yan
Zhou, Xinlong
Wang, Qingming
Li, Cong
Yuan, Haiming
Novel KCNJ16 variants identified in a Chinese patient with hypokalemic metabolic acidosis
title Novel KCNJ16 variants identified in a Chinese patient with hypokalemic metabolic acidosis
title_full Novel KCNJ16 variants identified in a Chinese patient with hypokalemic metabolic acidosis
title_fullStr Novel KCNJ16 variants identified in a Chinese patient with hypokalemic metabolic acidosis
title_full_unstemmed Novel KCNJ16 variants identified in a Chinese patient with hypokalemic metabolic acidosis
title_short Novel KCNJ16 variants identified in a Chinese patient with hypokalemic metabolic acidosis
title_sort novel kcnj16 variants identified in a chinese patient with hypokalemic metabolic acidosis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655507/
https://www.ncbi.nlm.nih.gov/pubmed/37466410
http://dx.doi.org/10.1002/mgg3.2238
work_keys_str_mv AT chenjianxiong novelkcnj16variantsidentifiedinachinesepatientwithhypokalemicmetabolicacidosis
AT fuyouqing novelkcnj16variantsidentifiedinachinesepatientwithhypokalemicmetabolicacidosis
AT sunyan novelkcnj16variantsidentifiedinachinesepatientwithhypokalemicmetabolicacidosis
AT zhouxinlong novelkcnj16variantsidentifiedinachinesepatientwithhypokalemicmetabolicacidosis
AT wangqingming novelkcnj16variantsidentifiedinachinesepatientwithhypokalemicmetabolicacidosis
AT licong novelkcnj16variantsidentifiedinachinesepatientwithhypokalemicmetabolicacidosis
AT yuanhaiming novelkcnj16variantsidentifiedinachinesepatientwithhypokalemicmetabolicacidosis